BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23477870)

  • 21. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.
    Hadrich I; Vandewalle P; Cheikhrouhou F; Makni F; Krichen MS; Sendid B; Standaert-Vitse A; Ayadi A; Poulain D
    Scand J Gastroenterol; 2007 Jun; 42(6):717-25. PubMed ID: 17505994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.
    Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K
    Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?
    Malickova K; Lukas M; Donoval R; Sandova P; Janatkova I
    Clin Lab; 2006; 52(11-12):631-8. PubMed ID: 17175895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.
    Sutton CL; Yang H; Li Z; Rotter JI; Targan SR; Braun J
    Gut; 2000 Jan; 46(1):58-63. PubMed ID: 10601056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
    Landers CJ; Cohavy O; Misra R; Yang H; Lin YC; Braun J; Targan SR
    Gastroenterology; 2002 Sep; 123(3):689-99. PubMed ID: 12198693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candida albicans colonization and ASCA in familial Crohn's disease.
    Standaert-Vitse A; Sendid B; Joossens M; François N; Vandewalle-El Khoury P; Branche J; Van Kruiningen H; Jouault T; Rutgeerts P; Gower-Rousseau C; Libersa C; Neut C; Broly F; Chamaillard M; Vermeire S; Poulain D; Colombel JF
    Am J Gastroenterol; 2009 Jul; 104(7):1745-53. PubMed ID: 19471251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG antibodies against common gut bacteria are more diagnostic for Crohn's disease than IgG against mannan or flagellin.
    Adams RJ; Heazlewood SP; Gilshenan KS; O'Brien M; McGuckin MA; Florin TH
    Am J Gastroenterol; 2008 Feb; 103(2):386-96. PubMed ID: 17924999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
    Kim BC; Park S; Han J; Kim JH; Kim TI; Kim WH
    Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease.
    Joossens M; Van Steen K; Branche J; Sendid B; Rutgeerts P; Vasseur F; Poulain D; Broly F; Colombel JF; Vermeire S; Chamaillard M
    Inflamm Bowel Dis; 2010 Jan; 16(1):58-67. PubMed ID: 19504613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.
    Hui T; Landers C; Vasiliauskas E; Abreu M; Dubinsky M; Papadakis KA; Price J; Lin YC; Huiying Y; Targan S; Fleshner P
    Dis Colon Rectum; 2005 Jun; 48(6):1254-62. PubMed ID: 15868228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
    D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
    Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of human leucocyte DR and DQ antigens in Crohn's disease in Asian Indians: a family study.
    Thakur S; Ranjan P; Ghoshal UC; Muller-Myhsok B; Khan F; Talwar S; Agarwal S
    Trop Gastroenterol; 2003; 24(4):185-8. PubMed ID: 15164528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intestinal permeability in relatives of patients with Crohn's disease].
    Kohout P; Koref P
    Vnitr Lek; 2001 Jun; 47(6):371-4. PubMed ID: 11494882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
    Ahrenstedt O; Knutson L; Nilsson B; Nilsson-Ekdahl K; Odlind B; Hällgren R
    N Engl J Med; 1990 May; 322(19):1345-9. PubMed ID: 2325733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease behavior in adult patients: are there predictors for stricture or fistula formation?
    Dotan I
    Dig Dis; 2009; 27(3):206-11. PubMed ID: 19786742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal mucosal immune response to altered bacterial flora following restorative proctocolectomy in patients with ulcerative colitis: serologic measures, immunogenetics, and clinical correlations.
    Sheikh S; Uno J; Matsuoka K; Plevy S
    Clin Immunol; 2008 Jun; 127(3):270-9. PubMed ID: 18499066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.
    Rieder F; Lopez R; Franke A; Wolf A; Schleder S; Dirmeier A; Schirbel A; Rosenstiel P; Dotan N; Schreiber S; Rogler G; Klebl F
    PLoS One; 2011 May; 6(5):e18172. PubMed ID: 21573154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
    Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
    Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.